Selective Pressure is an exciting, fast-paced quiz competition where teams of four compete for the Selective Pressure trophy and well-earned bragging rights for the year. Don't miss out on the fun! Sign up your winning team before next Friday, 20 March! ow.ly/SQ5S50Y811M

⏰Don't miss your chance to register for #ESCMIDGlobal2026 before standard registration rates end on 11 March 2026, and prices go up. Late registration rates start on 12 March 2026. 👀 Register now: https://ow.ly/eP0c50Yq7pn#ESCMIDGlobal2026 #IDSky #clinmicro

www.escmid.org/congress-eve... Hope to see many of my ID and CM colleagues in Munich!

In this 3rd collaboration between SIDP Breakpoints & ESCMID’s Communicable, Erin McCreary, PharmD & Angela Huttner host Pranita Tamma (USA) & Benedikt Huttner (WHO, Switzerland) to discuss #guidelines & guidance, offering a behind-the-scenes look into their development, reach - and limits. #IDSky

Wow.

The volume & geographic distribution of protest nationwide during year 1 of Trump's second term was extraordinary.

We deserve dignity in our future leaders For example, I remember a gracious and empathetic President and First Lady who treated all Americans with respect and vigorously championed innovative research for disease cures and evidence-based clinical care for children and other vulnerable populations

Kidney transplantation (KT) from donors with HIV to recipients with HIV is noninferior to KT from donors without HIV in terms of safety. In CID, authors describe the burden and timeline of post-KT infections and assess associations with HIV donor status. https://bit.ly/4jNGe8D

We lost a beloved a beloved ID colleague & friend unexpectedly this week. Dr. Lauren Collins' legacy and the many lives she touched will live on. A compassionate physician who was leader in the fight to end HIV locally and nationally. #IDSky gradyhealthfoundation.donorsupport.co/page/laurenc...

📣 Systematic review by @lcordes.bsky.social, @bwtrautner.bsky.social, @merellambregts.bsky.social et al assessing evidence for long #antibiotic durations in chronic bacterial #prostatitis. Spoiler: there isn’t much. #IDSky #clinmicro #UroSky #MedSky #OA #AMR www.sciencedirect.com/science/arti...

📚We launched ESCMID Media last year, where our members can watch everything from past webinars to sessions from #ESCMIDGlobal and other conferences! 👀Explore it now: https://media.escmid.org/#ESCMIDGlobal #IDSky #clinmicro

How do microbiomes drive—and solve—AMR? 🧫 Join IMARI 26 pre-meeting workshop “Microbiomes as Reservoirs, Catalysts, and Solutions for AMR” with Dr. Amy Mathers & Dr. Romney Humphries to learn more. Add it when you register ➡️ https://imari.org/registration/

🌍 For #WAAW2025, ISAC invited Member Societies to share efforts against #AMR Dr Dena van den Bergh explains a study by South African Antibiotic Stewardship Programme that aims to empower the next generation of leaders to implement AMS at scale Watch now: youtu.be/p2Jsaq3jhIE @souhakanj.bsky.social

🎙️ Just published: Communicable E40: AMR in conflict and crisis zones Hosted by Nav Narayanan & Thomas Tängdén w/ invited guests Aula Abbara (UK), Guido Granata (Italy), Tuomas Aro (Finland) Listen on #Communicable: #IDSky #Clinmicro #WAAW2025 #AMR @taescmid.bsky.social

📣 In a US cohort of >2500 #bacteremia patients, #Serratia marcescens was associated with persistent bacteremia and cardiac devices. Yet WGS showed genetic diversity of isolates: infections are not clonal. #IDSky #clinmicro #MedSky @vancefowler.bsky.social www.cmi-comms.org/article/S295...

Gave my 1st talk in NL: how to make multicenter data analysis with patient data actually work. tl;dr: common data models (global interoperability) + LLMs (data harmonization, mapping, future-proofing) + federated learning (privacy) Let me know what you think! drive.google.com/file/d/1N3yk...

Looking forward to UNC Institute of Global Health and Infectious Diseases Friday talk globalhealth.unc.edu/education/fr...

🎯

Peri–Covid-19 antibiotic use was associated with downstream antimicrobial resistance, and particularly the presence of gram-negative antibiotic-resistant organisms @nejm.org evidence.nejm.org/doi/full/10....

Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight: See next posts

Getting ready for #IDBugBowl @idweek.bsky.social Hope to see y’alll this afternoon. Come and cheer ur team UAB CCF ThomasJefferson and our international team Calcutta Troo Med #IDWeek2025 #IDSky

Dr Cesar Arias delivers Maxwell Finland Lecture #IDweek2025 “Antimicrobials save the patient and reduce infectiousness” “My research comes from a question in one patient” 💯

Dr Yohei Doi now introducing Dr. Cesar Arias as the Maxwell Finland lecturer. #IDWeek2025 A pioneer in AMR research 🤩

As #IDWeek2025 begins, thousands of ID experts are uniting to defend science and public health. Urge Congress to fully fund ID research, preparedness and care, and hold the Administration accountable. Your voice matters. Take action: https://idsociety.quorum.us/campaign/144678/

Dr Tamma: Susceptibility for cefuroxime, cefoodoxime, cefdinir, cefixime looking encouraging in ceftriaxone-susceptible Enterobacterales from BSI at Hopkins. #IDweek2025 #IDsky pubmed.ncbi.nlm.nih.gov/39745384/

Dr Tamma mentions the ongoing GOAT trial (PI Tamma & Cosgrove) This will be a most needed and important study. clinicaltrials.gov/study/NCT060... #IDweek2025 #IDsky

Dr Tamma now discusses the interpretation of ceftriaxone susceptibility testing for the use of oral cephalosporins. #IDweek2025 #IDsky Most people in observational studies of GN BSI were transitioned to oral late, and mostly to FQ or tmp/smx

Don’t miss @bwtrautner.bsky.social and I talk about what’s new in UTI (the UTI WikiGuideline and IDSA cUTI guideline) on Wednesday AM at 08:00 EST! #idweek2025 #idsky

Welcome to Atlanta #IDWeek2025! Check out this great guide to our city from the #EmoryID fellows! The Eastside Beltline is my fave

Dr Molina now discusses the important ARLG study DOTS. Primary outcome was a desirability of outcome ranking analysis Similar in dalba vs SOC #idweek2025 #idsky

Curious about new antibacterials in the pipeline? Check out Monday 8am session in B302 and be (among) the first to know. #IDweek2025 #IDsky

Dr. Molina now summarizing data on the use of long-acting anti-gram-positive bacterial agents: dalbavancin, and oritavancin #IDweek2025 #IDsky

Nice summary by Dr. Nguyen on the use of oral B-lactams. Concerns over cefdinir bio availability. Overall limited but encouraging data for use in streptococcal infections. Probably too soon for MSSA. #IDWeek2025 #IDsky

Please join us this Monday 8-9 am at IDWeek. Difficult-to-treat mold infections. Dimitrios Farmakiotis will be discussing treatment of mucormycosis. I will be discussing aspergillosis.

Don’t throw away your shot to watch the #IDWeek2025 Opening Plenary live! Tune in at 3:45PM ET to see Javier Muñoz and other special guests kick off the meeting: https://idweek2025.eventscribe.net/aaStatic.asp?SFP=WldXSkRZU0dAMjQyMjY

#IDWeek2025 let’s go! #IDsky

This is an awesome opportunity @escmid.bsky.social @taescmid.bsky.social @idsainfo.bsky.social

An early look at next week’s cover: "Remote Control,” by Barry Blitt. nyer.cm/6ApBXER

Ever since I learned about this study enrolling I have been eagerly awaiting the results. Researchers in Uganda took a centuries-old cultural practice mothers carrying babies on their backs in cloth wraps and turned it into a public health tool. You got to love it! www.nejm.org/doi/full/10....

🎙️ Just published: Commun... Hosted by @angelahuttner.bsky.social & @erinmccreary.bsky.social w/ invited guests: Nick Daneman & Rob Fowler (Sunnybrook Health Sciences Centre) Listen on @sidpharm.bsky.social: https://sidp.pinecast.co/ Listen on Communicable: #IDSky #Clinmicro #MedSky

Infection with antimicrobial-resistant organisms significantly worsens outcomes in cancer patients A survey of oncologists offers data that could support the development of oncology-specific AMS strategies and training programs: doi.org/10.1093/jaca... #IDSky #JACAMRNews

Dr. Michael Herce discusses this concept and how it works to improve access to healthcare for populations who have been disproportionately burdened by various infectious diseases such as HIV, tuberculosis, and COVID-19. @uncglobalhealth.bsky.social #IDsky #Medsky

Justice Sotomayor is crystal clear in dissent as to what's happening: "We should not have to live in a country where the Government can seize anyone who looks Latino, speaks Spanish, and appears to work a low wage job. Rather than stand idly by while our constitutional freedoms are lost, I dissent."

New Research: Global policy responses to antimicrobial resistance, 2021–22: a systematic governance analysis of 161 countries and territories www.thelancet.com/journals/lan...

Dr. Jeanne Marrazzo, until recently head of NIAID and Dr. Kathy Neuzil (incredible public servants and scientists!) document the extent of political interference with science at NIAID. Whistle-Blower Complaints Detail Tension Over Vaccines at N.I.H. www.nytimes.com/2025/09/04/h...

The great @maclomaclee.bsky.social on the future of journal articles: as the numbers of journals, articles increase, the value of the information they provide diminishes or depreciates. Discrete actions can help sustain the value as an economic (and moral?) good @edinburgh-uni.bsky.social #CAMARADES

Just came across this preprint: groups at @broadinstitute.org and MGH developed a low-cost, #CRISPR based diagnostic for pathogenic bacteria and #AMR genes from blood cultures.

As the trump administration dials back surveillance for and prevention of infectious diseases guess what the biggest threat to our health systems is right now? That's right, infectious diseases.

Joseph Eron, MD, provides insights on their international reach as well as some of the important trials they have been involved in, notably the PURPOSE studies involving the landmark trials around #lenacapavir for HIV prevention. #IDsky #Medsky

“I think of antibiotics as infrastructure” @yhgrad.bsky.social interviewed for the Harvard Gazette, 'Racing against antibiotic resistance'. Read it here at bit.ly/47PdOqv